*** 4/19 8:00 Takeda Pharmaceutical Company Limited submitted "U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease"  *** 4/18 17:05 Nippon Denkai, Ltd. submitted "Notice Regarding Recording of Additional Extraordinary Profit (Insurance Receipt) "  *** 4/18 17:00 SAKATA SEED CORPORATION submitted "Notice Concerning Status of Acquisition of Own Shares and Completion of Acquisition"  *** 4/18 17:00 HASEKO Corporation submitted "Corporate Governance Report"  *** 4/18 17:00 BASE, Inc. submitted "Notice Concerning the Issuance of New Shares as Restricted Stock-Based Compensation"

TAMAGAWA HOLDINGS CO., LTD. [6838] [E01864]